sulotroban has been researched along with Coronary Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bass, T; Bove, AA; Deutsch, E; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, A; Vetrovec, G; Whitworth, HB | 1 |
| Bass, TA; Bove, AA; Cowley, M; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, AS; Vetrovec, G; Whitworth, HB | 1 |
| Guth, BD; Ross, J; Schulz, R; Thaulow, E | 1 |
| Bulitta, M; Etti, H; Finci, L; Höfling, B; Ludwig, B; Meier, B; Steffenino, G | 1 |
| Bleifeld, W; Hamm, CW; Kupper, W; Terres, W | 2 |
| Berk, L; van der Giessen, WJ; Verdouw, PD; Zijlstra, FJ | 1 |
| Brezinski, ME; Darius, H; Lefer, AM; Yanagisawa, A | 1 |
| Schrör, K; Thiemermann, C | 1 |
| Parratt, JR; Wainwright, CL | 1 |
| Bugelski, PJ; Granett, JR; Shebuski, RJ; Smith, JM; Storer, BL | 1 |
4 trial(s) available for sulotroban and Coronary Disease
| Article | Year |
|---|---|
Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Sulfonamides; Thromboxane A2; Time Factors; Treatment Outcome | 1995 |
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Mid-Atlantic Region; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Prostaglandin; Receptors, Thromboxane; Recurrence; Sulfonamides; Thromboxanes | 1991 |
Sulotroban during and after coronary angioplasty. A double-blind, placebo controlled study.
Topics: Angioplasty, Balloon; Anti-Arrhythmia Agents; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Randomized Controlled Trials as Topic; Recurrence; Sulfonamides | 1989 |
[Myocardial resting ischemia after intravenous infusion of a thromboxane-receptor antagonist].
Topics: Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Sulfonamides | 1987 |
7 other study(ies) available for sulotroban and Coronary Disease
| Article | Year |
|---|---|
Selective thromboxane A2 receptor blockade in experimental exercise-induced myocardial ischaemia in dogs.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Heart Rate; Hemodynamics; Myocardial Contraction; Physical Exertion; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1989 |
Resting myocardial ischemia after intravenous infusion of BM 13.177 (sulotroban), a thromboxane receptor antagonist.
Topics: Coronary Circulation; Coronary Disease; Fibrinolytic Agents; Humans; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1987 |
The effect of the thromboxane receptor antagonist BM 13.177 on experimentally induced coronary artery thrombosis in the pig.
Topics: Animals; Anti-Arrhythmia Agents; Aspirin; Coronary Disease; Coronary Thrombosis; Electric Stimulation; Hemodynamics; In Vitro Techniques; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Swine; Thromboxane B2 | 1988 |
Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
Topics: Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Heart Rate; Myocardium; Pancreas; Platelet Aggregation; Proteins; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1985 |
Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
Topics: Adenosine Triphosphate; Animals; Blood Platelets; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Fibrinolytic Agents; Heart Rate; Hemodynamics; Myocardium; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Time Factors | 1986 |
Antiarrhythmic effects of the thromboxane antagonist BM 13.177.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbon Dioxide; Coronary Disease; Dogs; Hemodynamics; Oxygen; Sulfonamides; Thromboxanes | 1987 |
Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Female; Fibrinolytic Agents; Male; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Tissue Plasminogen Activator | 1988 |